Cetuximab Plus Capecitabine and Irinotecan Compared With Cetuximab Plus Capecitabine and Oxaliplatin As First-Line Treatment for Patients With Metastatic Colorectal Cancer: AIO KRK-0104—A Randomized Trial of the German AIO CRC Study GroupNicolas Moosmann, Volker Heinemann, Holger G. Hass et al.|Journal of Clinical Oncology|2011Cited by 117
Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trialJobst C. von Einem, Dominik Paul Modest, Volker Heinemann et al.|Journal of Cancer Research and Clinical Oncology|2014Cited by 112